Menu Search
Equities

Sotac Pharmaceuticals Ltd

SOTAC:NSI

Sotac Pharmaceuticals Ltd

Actions
  • Price (INR)150.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.20k
  • 1 Year change+22.95%
  • Beta--
Data delayed at least 15 minutes, as of Sep 17 2024 04:47 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Sotac Pharmaceuticals Ltd had revenues fall -20.74% from 731.52m to 579.83m, though the company grew net income 56.17% from 28.79m to 44.96m.
Gross margin30.90%
Net profit margin7.75%
Operating margin11.35%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

In 2023, Sotac Pharmaceuticals Ltd increased its cash reserves by 34,676.81%, or 95.71m. Cash Flow from Financing totalled 119.65m or 20.64% of revenues. In addition the company generated 85.36m in cash from operations while cash used for investing totalled 109.31m.
Cash flow per share6.41
Price/Cash flow per share27.08
Book value per share14.31
Tangible book value per share14.31
More ▼

Balance sheet in INRView more

Sotac Pharmaceuticals Ltd has a Debt to Total Capital ratio of 48.06%.
Current ratio1.35
Quick ratio0.9968
Total debt/total equity0.9252
Total debt/total capital0.4806
More ▼

Growth rates in INR

Year on year, growth in earnings per share excluding extraordinary items increased 114.20%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.